INOVIO Grants Equity Award Under 2022 Inducement Plan

INOVIO Pharmaceuticals

PLYMOUTH MEETING, PAINOVIO (NASDAQ: INO) has announced a stock option grant to a newly hired employee under its 2022 Inducement Plan. The award was approved by INOVIO’s Compensation Committee as per Nasdaq Listing Rule 5635(c)(4).

The equity grant, dated November 30, 2024, includes an option to purchase 1,666 shares of common stock. The exercise price for the stock option is set at $4.32, based on the closing price of INOVIO’s common stock on November 29, 2024, the last trading day before the grant date.

READ:  BrightView Raises Revenue Outlook After Maintenance Growth

The stock option follows a structured vesting schedule. One-fourth of the shares will vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second, and third anniversaries of the grant date. Full vesting is contingent upon the new employee’s continued employment with INOVIO through the applicable dates.

This grant was issued in accordance with the terms and conditions of INOVIO’s 2022 Inducement Plan and governed by a stock option agreement specific to this award.

The equity award reflects INOVIO’s ongoing effort to attract and retain skilled professionals through competitive incentive programs.

READ:  Toll Brothers Names COO Successor Ahead of Retirement

Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.